Limited and External Funding Opportunities

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

 

Have you been awarded a Limited Submission recognition?

Please let us know at LSO@vanderbilt.edu


covid

Special Research Focus: COVID-19 Funding Opportunities

Curated collections of funding opportunities

Edge for Scholars offers curated list of COVID-19 funding opportunities

Updated regularly. Check the site often for updates about research funding opportunities, including to special calls & announcements, in response to the coronavirus pandemic. 

GrantForward funding database provides list of COVID-19 funding opportunities


Research Awards Banner.png

Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigator

2022 Mallinckrodt Scholars Program

Applications due October 28, 2021

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU and VUMC, collaboratively) anticipates the opportunity to nominate two candidates for the Edward Mallinckrodt, Jr Foundation Scholar Award Program. The Foundation supports early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. This award typically provides $400,000 over four years in order to move a project forward to the point where other independent funding can be obtained. No indirect costs are allowed.

Eligibility Requirements:

  • Hold M.D. and/or Ph.D. degree
  • In 5th to 8th year of a tenure-track position
  • Candidates may have an R01

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5:00 p.m. on October 28, 2021: 

  1. Brief research lay summary (1/2 page max);
  2. Brief research plan including summary budget (2 page max including summary budget);
  3. Letter of support from department chair/center director;
    1. Letter must additionally acknowledge that this grant does not allow indirect costs.** This statement can be used/modified within the letter: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable school/institutional policy.”
  4. NIH Biosketch or Brief CV (5 page max)

**Process for cost-sharing typically coordinated at the departmental/school level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Submissions should reference the program name in the subject line of the email. All applicants should verify their eligibility in advance through the foundation website.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NIH Collaborative Program Grant for Multidisciplinary Teams (RM1- Clinical Trial Optional)

Applications due November 4

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit one proposal to the January 2022 cycle of the NIH Collaborative Program Grant for Multidisciplinary Teams (RM1). The program is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of National Institute of General Medical Sciences (NIGMS) and are beyond the scope of an individual or a few investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. While applications may request research program budgets of up to $1.5 million direct costs per year, it is anticipated that most awards will be between $700,000-$900,000 direct costs.

Eligibility:

Successful applications will bring together scientists to apply complementary approaches to work on an important and well-defined problem. Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations. NIGMS also supports research in a limited number of clinical areas that affect multiple organ systems (see here for scientific areas supported by NIGMS).

Truly new interdisciplinary ideas for approaching significant biological problems are encouraged. Applications that bridge the research interests of more than one NIGMS division are also encouraged, but must remain within the scope of the NIGMS mission. Consultation with NIGMS staff prior to preparing an application is strongly encouraged.

We recommend that applicants review the RFA in detail to review the research areas that are within the NIGMS mission. Applications that focus solely on a specific organ or disease state and that are within the mission areas of other NIH Institutes and Centers are not appropriate for this FOA. Applications that employ specific cells or tissues to address a fundamental biomedical question are appropriate.

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies or infrastructure development are not appropriate for this FOA.

See the solicitation for more information.

Internal Application Process:

Anyone interested in being considered to submit VUMC’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on November 4:

  • Brief project description including summary budget and role of each PI (2 page max);
  • Letter of support from department chair/center director;
  • NIH Biosketch for all PIs

Full applications are due to NIH by January 27, with an LOI requested 30 days prior. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2022 SebastianStrong Foundation Discovery Science Award

Applications due November 8, 2021

VUMC: These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

VUMC can select two candidates for the 2022 SebastianStrong Foundation Discovery Science Award. The SebastianStrong Foundation is committed to raising awareness about and finding less toxic cures for pediatric cancers. SebastianStrong funds cutting-edge, peer-reviewed pediatric research projects in early stages. The Foundation believes in supporting bold ideas that use innovative methodologies and out-of-the-box approaches in the quest for less toxic cures.

The 2022 Discovery Science Award will be awarded to an individual or team of researchers whose proposal is focused primarily on pediatric cancers in general, or a specific pediatric cancer without a high survival rate or one with a low survival rate upon relapse. Budgets are flexible but awards are typically between $100,000 and $300,000. The foundation has historically limited overhead costs to a maximum of 15%.

Research Proposal Criteria:

  • Proposal should be focused on pediatric cancer.
  • Research will lead to “less toxic” cures.
  • Proposal can be understood by the foundation’s Board of Directors and donors (e.g. use examples and spell out acronyms).
  • Research may lead to a clinical trial in 1-3 years.
  • Peer-reviewed new, ongoing, and/or updated research is appropriate.
  • Trials in progress or ongoing clinical trials are not eligible.

See descriptions of previous award winners here.

Internal Application Process:

Anyone interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on November 8. Submissions should reference “SebastianStrong Discovery Science Award” in the subject line of the email.

  1. Brief lay-summary of the research including a summary budget (2-page maximum)
    1. A clear explanation, understandable by donors and the Board of Directors is a key component of consideration
  2. Letter of support from department chair/center director
  3. NIH Biosketch or brief CV (5-page maximum)

Any questions about this opportunity or the LSO process can be directed to LSO@vanderbilt.edu


2022 Brain Research Foundation - Seed Grant Program

Applications due November 9, 2021

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions

Overview:

Vanderbilt (VU and VUMC, collaboratively) may nominate one candidate for the Brain Research Foundation Seed Grant Program for 2022. This award provides $80,000 (direct costs) over two years to support new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources. The objective of the BRF Seed Grant Program is to support new and innovative neuroscience projects, especially those of junior faculty, who are working in new research directions. Funds must be utilized within the grant period.

Eligibility:

  • PI must be a full-time Assistant or Associate Professor working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease.
    • Assistant Professor – Junior faculty with a new research project that will generate pilot data that will lead to R01 funding or a comparable outside grant will be first priority.  Must provide abstract and specific aims for current grants and indicate if there is any overlap.
    • Associate Professor – Faculty who are pursuing new research directions. Must explain how the project is a new research direction. A new technique is not considered a new direction unless it pertains to a different area of study. Must provide abstract and specific aims for current grant(s) and indicate if there is any overlap.
  • Research assistant professors, research associate professors, and Full Professors are not eligible.
  • The grant proposal must detail a new research project that is not funded by other sources.
  • All applicants should verify their eligibility in advance through the foundation website.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on November 9, 2021

  1. Brief research plan including summary budget (2 page max including budget);
    • Include closing paragraph that explains how this research will develop (next steps)
    • Refer to budget guidelines
  2. Letter of support from department chair/center director;
    • Letter must additionally acknowledge that this grant does not allow indirect costs.** This statement can be used/modified within the letter: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable school/institutional policy.”
  3. NIH Biosketch (5 page max)
    • Biosketch should contain “other support page”

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Submissions should reference the program name in the subject line of the email. Vanderbilt’s nominee will submit a required LOI to the Foundation by January 4, 2022.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


St. Baldrick’s Foundation Scholar (Career Development) Awards

Applications due November 11, 2021

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU & VUMC combined) may submit one Scholar (Career Development) Award proposal for the St. Baldrick’s Foundation spring grant cycle. The St. Baldrick’s Foundation is a nonprofit organization raising funds for childhood cancer research. All projects must have direct applicability and relevance to pediatric cancer.

The Scholar (Career Development) Award is meant to help develop the independent research of highly qualified individuals still early in their careers. This award is granted for two years with an opportunity to apply for an additional three years of funding based upon the demonstration of significant accomplishment. Funding for years 1–2 will be up to $110,000 per year (up to $115,000 per year for years 3–5), to be used entirely for the Scholar’s salary and fringe at the applicant institution.

Topics of interest include, but are not limited to:

  • Adolescents & young adults
  • Survivorship, outcomes, and quality of life
  • Supportive care
  • Epidemiology and pediatric cancer predispositions
  • Precision medicine
  • Alternative & complementary therapies

There is particularly high interest in the following. (Research on these conditions may qualify for an additional institutional submission, and therefore may receive priority.)

  • Brain tumors – all types, including rare forms 
  • Burkitt lymphoma
  • Complementary and alternative therapies
  • Hepatoblastoma
  • Langerhans Cell Histiocytosis
  • Rhabdoid tumors

Eligibility Requirements:

Applicant Eligibility

  • Research projects must have direct applicability and relevance to pediatric cancer. They may be in any discipline of basic, clinical, translational, or epidemiological research.
  • Applicants should hold a Ph.D., M.D., or D.O. degree in a field of research specialty by the date the award becomes effective.
  • Applicants must currently hold (for no longer than 7 years at the time the award begins), or will hold by start of the award, a title that is considered by the institution to be a fulltime, faculty position. (Contact lso@vanderbilt.edu with any questions about eligible positions.)
  • This is an early-career award. The Scholar award is intended to develop the independent pediatric cancer research careers of highly qualified investigators, not to support well established or senior investigators.
  • Scholars may receive funding from other sources to support their research. However, no other comparable or higher (monetary value) career development award may be held prior to or at the time the award begins. Scientific or budgetary overlap with other funded projects is not allowed.
  • Applicants holding or awarded R01s at the time of the LOI are not eligible to apply. Applicants cannot hold a NIH K-award at the time that they apply (institutional K12 funding is allowable). If other awards are received after application, adjustments to the Scholar award may be possible – see guidelines.
  • Applicants must have an appropriate Sponsor who provides supervision, facilities, and research support. If appropriate for the project, applicants may have more than one (1) Sponsor.

Additional Conditions of Award

  • Scholar awards are to be used entirely for the Scholar’s salary and fringe at the applicant institution. Other personnel and/or non-personnel costs are NOT allowed on Scholar awards.
  • No institutional overhead or indirect funding is allowed.
  • The Scholar must devote no less than 40% effort to the funded project.
  • St. Baldrick’s funds may not be used for human embryonic stem cell research.

Applicants should review full eligibility and budget requirements in the Scholars grant guidelines document.

Internal Selection Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on November 11, 2021.

  1. Research plan (2 page max)
    1. If your research will focus on any of the six high-interest areas listed above, please identify the area
  2. Letter of support from department chair/center director;
    1. Letter must additionally acknowledge that this grant does not allow indirect costs.** This statement can be used/modified within the letter: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable school/institutional policy.”
  3. NIH Biosketch or brief CV (5 page max)

Submissions should reference the program name in the subject line of the email. Following internal selection, Vanderbilt’s nominee(s) will submit a Letter of Intent to St. Baldrick’s by December 3, 2021.

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.


 

Research Awards Banner.png

Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


BrightFocus Foundation - Alzheimer's Disease Research Grants and Postdoctoral Fellowships

Applications due November 1

BrightFocus Foundation provides research funds for researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer's disease. BrightFocus grants cover a wide range of investigator-initiated topics to accelerate the understanding of the biological mechanisms underlying Alzheimer’s disease and related dementias.

Full Proposal deadline: 1 November 2021, 5:00 PM EST

Amount: $100,000 per year

Award durations: Standard Awards can be up to 3 years. Fellowship Awards can be up to 2 years.

Eligibility: Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency). All other applicants are encouraged to apply for a standard award.

Scope: The goal of the program is to accelerate our understanding of the biological mechanisms underlying Alzheimer’s Disease and related dementias as well as innovative approaches to better diagnose, prevent or delay the progress of the disease. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically, these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research.


Doris Duke Charitable Foundation 2022 Clinical Scientist Development Award

Pre-applications due November 12

The Doris Duke Clinical Scientist Development Award provides grants to junior physician scientists to facilitate their transition to independent clinical research careers. Pre-proposal applications are being sought from Assistant Professor physician scientists conducting clinical research in any disease area.  

The Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years. The priority of the CSDA program is to fund outstanding individuals with potential for clinical research careers, substantial institutional commitments to mentorship and career development, and whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities based on disease area or research type.

The Doris Duke Charitable Foundation recognizes that a diverse workforce that represents the demographics of the population of the United States is better poised to address health issues affecting all communities. DDCF strongly encourages individuals from groups underrepresented in biomedical research to apply because DDCF is committed to the retention and advancement of early-career physician scientists who are conducting seminal clinical research and who belong to populations whose exclusion from research based on their race, ethnicity, gender, disability, sexual orientation, or socioeconomic background has resulted in underrepresentation in the workforce.

In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or tissues derived from animals, including cell lines, will not be supported by this program.

The Clinical Scientist Development Award does not require institutional nomination. This competition employs a two-stage process. Pre-proposal applications will be reviewed and approximately 50 applicants will be invited to submit a full proposal. 

Application Deadlines

  • Eligibility exemption requests due:  October 15, 2021, 5pm ET
  • Pre-proposal applications due: November 12, 2021, 3 pm ET
  • Invitation to submit full proposal: By 5 pm ET on January 14, 2022
  • Full proposals due: March 11, 2022, 3 pm ET
  • Award start date: July 1, 2022 

Please contact Sue Reeves, Executive Director of Foundation Relations (sue.reeves@vumc.org | Office: (615) 936-2964) for additional details about the application process.


Alkermes Pathways Research Awards

Applications due November 12

 

alkermes

Visit the program site here: https://www.alkermes.com/research-and-development/pathways


Howard Hughes Medical Institute (HHMI) Hanna H. Gray Fellows Program

Applications due December 1, 2021 by 3:00 pm Eastern

The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds. Through their successful careers, HHMI Hanna Gray Fellows will become leaders in academic research and inspire future generations of scientists from America's diverse talent pool.

Fellows will receive funding for their postdoctoral training and may continue to receive funding during their early career years as independent faculty. The program includes opportunities for career development, including mentoring and active involvement in the HHMI scientific community.

Eligibility:

  • The program is open to individuals who:
    • are from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds.
    • are basic science researchers and physician-scientists in the biomedical and life science disciplines.
    • hold a PhD and/or MD (or equivalent) from a research institution in the U.S., which must be conferred by the start of the grant term.
    • have been accepted to join a laboratory as a postdoctoral researcher at an academic research institution located in the U.S. at the time of the application due date.
  • The postdoctoral training mentor must hold a tenured or tenure-track position (or equivalent) at an institution in the U.S.
  • Applicants can have no more than 27 months of postdoctoral research experience at the time of the application due date.

See the program website, eligibility guidelines, application process, and FAQs for more information.

Applications must be submitted directly to HHMI by December 1, 2021 (3:00 pm Eastern)

Please contact Sue Reeves, Executive Director of Foundation Relations (sue.reeves@vumc.org | Office: (615) 936-2964) for additional details about the application process.


Damon Runyon Physician-Scientist Training Award 

Applications due December 1, 2021 by 3:00 pm Eastern

Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer.

In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon encourages more physicians to pursue research careers through a program designed to recruit outstanding U.S. Specialty Board-eligible physicians (MDs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their cancer clinical training.

The goals of the program are to:

  • transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer.
  • eliminate the financial disincentive to entering this career path.

The award will provide up to $460,000 over four years in financial support for the award recipient. In addition, the Foundation will retire up to $100,000 of medical school debt still owed. The application deadline for the Physician-Scientist Training Award is Wednesday, December 1, 2021.

Detailed information about the award, eligibility criteria, and application guidelines are available on the Foundation’s website: https://www.damonrunyon.org/for-scientists/application-guidelines/physi…;


The Michael J. Fox Foundation

Application due dates vary (see details below)

The Michael J. Fox Foundation (MJFF) funds promising research with a goal to significantly improve the lives of people with Parkinson's. They welcome applications from academia and industry for support to define, measure and treat Parkinson's. MJFF funds studies with sound scientific rationale and clear relevance for people with Parkinson's disease (PD). They support academic and industry scientists, small biotechs, big pharma, and allied care professionals and their portfolio spans basic, translational and clinical research.

MJFF is currently accepting applications for several funding opportunities, all with deadlines this fall:

Please contact Sue Reeves if you are interested in applying or have any questions about ADDF or these funding opportunities.

  • Sue Reeves, Executive Director of Foundation Relations, sue.reeves@vumc.org | Office: (615)936-2964